Export Import Guru

Exim SEO is an initiative by Barai Overseas to help its Client to get International reach in Export Business

Categories

4 Pharma Export Business Models for Indian Startups Without a Factory

4 Market Entry Strategies for Small-Budget Pharma Export Startups in India: How Merchant Exporters Can Build a Business Without a Factory

Many Indian entrepreneurs want to start a pharmaceutical export business but face one major challenge.

They have limited capital.

They may have access to manufacturers, understand basic export documentation and even identify potential international buyers.

However, when they approach the market, they discover that selling a new product is not easy.

Buyers may already have established suppliers.

Distributors may ask for credit facilities.

Some customers may want smaller quantities than manufacturers are willing to supply.

Others may require several different products in one shipment.

A new exporter may struggle to compete because the company does not have a recognized brand, extensive distribution network or sufficient working capital.

This creates an important question.

How can an Indian startup enter the pharmaceutical export business without owning a factory or investing large amounts of money in inventory?

One possible solution is to choose a suitable market-entry business model.

There is more than one way to participate in the pharmaceutical supply chain.

For example, a merchant exporter can specialize in small-batch products, consolidate products from different manufacturers, arrange contract manufacturing or investigate a toll manufacturing arrangement.

Each model solves a different business problem.

Each also involves different costs, responsibilities and risks.

Understanding these differences can help entrepreneurs select a business structure that matches their available resources.

In this article, we will examine four important pharmaceutical market-entry strategies:

Small-Batch Specialization Model.
Multi-Product Variety Consolidation Model.
Simple-Formula Contract Manufacturing Model.
Multi-Ingredient Toll Manufacturing Model.

We will also understand the role of Indian manufacturers, merchant exporters, private-label businesses, manufacturing licences, quality agreements, export documentation, buyer relationships and commercial payment terms.

The objective is to help small-budget entrepreneurs identify realistic opportunities rather than invest money without understanding the complete business.

Why Market Entry Is Difficult for New Exporters

Imagine that you establish a new export company.

You identify a pharmaceutical product and obtain a competitive quotation from an Indian manufacturer.

You then approach an international distributor.

The distributor tells you:

"We already have suppliers. Why should we purchase from your company?"

You explain that your product is good and your price is attractive.

But the buyer still hesitates.

The distributor may be concerned about product registration, quality, delivery reliability or demand.

It may also ask for credit terms.

For a new company with limited working capital, offering substantial credit can create financial risk.

Suppose you invest your money in manufacturing and shipping the product.

If the buyer delays payment, you may not have enough capital to finance another shipment.

Even a commercially profitable order can create cash-flow problems.

Therefore, the biggest challenge is not always finding a manufacturer.

It is developing a reason for buyers to work with your company while keeping the business financially manageable.

This is where market-entry strategy becomes important.

The Problem with Competing Only on Price

Many startups believe that offering the lowest price is the best way to enter a market.

However, an established distributor may already have negotiated attractive rates with its existing suppliers.

A new exporter may reduce its selling price without creating a meaningful advantage.

This can leave very little margin to cover logistics, documentation, product inspection, banking charges and unexpected expenses.

Price competition also becomes difficult when a larger exporter can purchase greater quantities.

A small company may not have the same purchasing power.

Therefore, a startup needs to identify other ways to create value.

For example, the exporter may be able to supply a specialized product in a manageable quantity.

It may combine several product categories into one shipment.

It may arrange suitable private-label manufacturing.

Or it may coordinate a more specialized sourcing and manufacturing process.

These are different ways to solve buyer problems.

A strong market-entry strategy should answer three questions.

What problem does the buyer face?

How can the exporter solve that problem?

Can the exporter deliver the solution profitably and legally?

Why Pharmaceutical Merchant Exporting Offers Different Business Models

Pharmaceutical manufacturing involves specialized facilities, technical personnel, quality systems and regulatory controls.

However, every company involved in pharmaceutical business does not necessarily manufacture the products it sells.

Different businesses may perform different roles.

A manufacturer produces medicines under the applicable authorizations.

A marketing company may develop and distribute products under suitable arrangements.

A merchant exporter may purchase products from qualified manufacturers and supply them to international buyers.

A contract manufacturing company may produce medicines for another business according to an agreed arrangement.

A regulatory partner or overseas importer may help manage destination-market requirements.

These roles can create opportunities for companies that do not own factories.

However, they also involve legal responsibilities.

A merchant exporter cannot assume that owning a brand or paying a manufacturer allows it to produce or sell any medicine without the required permissions.

The product, manufacturing process, labelling and export transaction must comply with the applicable laws.

Let us examine the four strategies.

Strategy 1: Small-Batch Specialization Model

The first approach is small-batch specialization.

This model focuses on serving customers who need specific products in quantities that may be commercially unattractive to large-volume suppliers.

For example, a foreign distributor may require a particular approved formulation, pack size or specialized presentation.

The total quantity may be relatively small.

A large manufacturing company might be unwilling to accept the order because its production schedule is designed around larger commercial batches.

Another qualified manufacturer may already have a suitable production line and be willing to manufacture the required quantity.

A merchant exporter can investigate these differences and connect the buyer with an appropriate manufacturing partner.

The value comes from matching the buyer's requirement with the right supplier.

What Does Small-Batch Specialization Mean?

Small-batch specialization does not simply mean purchasing small quantities of ordinary products.

It means developing expertise in a defined product segment where manageable order quantities and suitable manufacturing arrangements are important to customers.

For example, a business may focus on selected authorized herbal products with specialized packaging.

Another may work with a manufacturer that can supply a limited number of approved product presentations.

A third may coordinate a small order across existing registered products and available manufacturing stock.

The important factor is that the business has access to qualified manufacturing capacity suited to the buyer's requirements.

However, medicines cannot simply be produced in arbitrary small batches without considering process validation, testing and licensing requirements.

A smaller commercial order is not necessarily the same as a smaller manufacturing batch.

A manufacturer may produce a validated batch and allocate an agreed quantity to an eligible customer, subject to the applicable quality and distribution controls.

Why Some Buyers Need Smaller Quantities

International buyers may require smaller orders for several reasons.

For example, a distributor may want to evaluate a new supplier before making larger commitments.

Another buyer may serve a relatively small population.

Some products may have limited but legitimate demand.

Other buyers may want to avoid holding excessive inventory near the product's expiry date.

For a startup exporter, understanding these requirements can create a commercial opportunity.

However, the exporter should first establish whether the destination country permits the product to be imported and supplied.

An importer cannot automatically conduct a commercial trial simply because the quantity is small.

Market authorization and applicable import requirements remain important.

Do Small Manufacturers Always Produce Better Quality?

No.

The video highlights the possibility that smaller production units can serve specialized requirements effectively.

This can be true where a manufacturer has appropriate expertise and flexible operations.

However, small-scale production does not automatically guarantee better quality.

A large manufacturing facility may have excellent quality systems.

A small facility may also have excellent quality systems.

The relevant factors are manufacturing authorization, qualified personnel, suitable equipment, process controls and product-specific testing.

In pharmaceutical manufacturing, Good Manufacturing Practice requirements apply according to the relevant regulatory framework.

A startup should never choose a supplier simply because its factory is small.

It should choose a manufacturer that can meet the product specification and quality requirements consistently.

Advantages of Small-Batch Specialization

This model may help an exporter serve buyers whose quantity requirements do not match those of larger suppliers.

It can also allow the entrepreneur to focus on a limited product category rather than managing a very large portfolio.

A specialized exporter may develop stronger product knowledge.

For example, the business may understand the required technical documents, packaging options and buyer expectations for a narrow product range.

This can improve communication and supplier selection.

However, the model also has limitations.

Small batches may have higher manufacturing and testing costs per unit.

The manufacturer may charge additional setup fees.

Packaging minimum order quantities may still be significant.

Some products may be uneconomical below a particular production volume.

Therefore, the exporter should calculate the complete cost before accepting the order.

Who Should Consider This Model?

Small-batch specialization may be worth investigating for an entrepreneur who has access to qualified manufacturers offering relatively flexible commercial arrangements.

It may also suit a company targeting a narrow, clearly defined customer category.

For example, a startup could evaluate whether a qualified manufacturer can support an approved product that a small overseas distributor regularly requires in manageable quantities.

The objective should be to establish a repeatable supply arrangement rather than purchase random small batches without confirmed demand.

Strategy 2: Multi-Product Variety Consolidation Model

The second approach is multi-product consolidation.

This is one of the most interesting models for merchant exporters because it can create value without requiring the exporter to manufacture products.

Let us understand the problem from the buyer's perspective.

Imagine that an overseas pharmaceutical distributor wants to purchase several different products from India.

The buyer may require tablets from one manufacturer, an authorized herbal product from another and selected surgical or healthcare consumables from a third.

Each manufacturer has a different minimum order quantity.

Each also has separate documentation, payment and dispatch arrangements.

Managing several suppliers can become time-consuming.

The importer may need to coordinate multiple shipments and purchase orders.

A capable merchant exporter may help reduce some of this complexity.

This is called consolidation.

What Is Multi-Product Consolidation?

In this model, the merchant exporter sources several products from suitable manufacturers and coordinates them into a commercially efficient supply arrangement.

For example, a buyer may request five related pharmaceutical products in different quantities.

The exporter identifies qualified manufacturers that can supply the required items.

The exporter then coordinates procurement, product verification, documentation and shipment planning.

Where commercially and legally suitable, products may be consolidated into one shipment.

However, not every medicine or healthcare product can be stored or transported together.

Some products require refrigeration.

Others have special handling requirements.

Certain products may be subject to controlled-substance regulations or specific segregation requirements.

Therefore, consolidation must be planned according to product compatibility and regulatory obligations.

Why International Buyers May Prefer Consolidation

A distributor may prefer purchasing through a consolidated supply partner for practical reasons.

First, it may reduce the number of supplier relationships the buyer must manage.

Second, it can simplify commercial coordination.

Third, it may help manage smaller quantities across a wider product range.

Fourth, it may improve shipment planning where products have compatible transport conditions.

Fifth, it can create one commercial point of contact for discussing schedules, documentation and order status.

However, these benefits must be demonstrated.

A consolidated shipment does not automatically reduce costs.

If products originate from distant factories, domestic transportation and handling expenses may increase.

Different manufacturing lead times can also delay the entire shipment.

Therefore, the exporter should calculate whether consolidation genuinely benefits the buyer.

A Practical Consolidation Example

Imagine that an overseas distributor requests four products.

Product A is available from Manufacturer 1.

Product B is available from Manufacturer 2.

Products C and D are available from Manufacturer 3.

The buyer wants different quantities of each product.

The merchant exporter contacts all three manufacturers and requests quotations.

Next, the exporter checks whether the manufacturers can provide the necessary technical and commercial documents.

The exporter confirms the product registration and import requirements with the overseas buyer.

Then the parties agree on quantities, pricing and delivery arrangements.

The exporter coordinates shipment planning through appropriate logistics providers.

If the products have compatible storage and transport requirements, physical consolidation may be feasible.

If not, separate shipments may be necessary.

The exporter still creates value by coordinating the overall sourcing arrangement.

This demonstrates that commercial consolidation does not always require every item to be placed in one container.

Sometimes the service is coordinating multiple suppliers through a unified purchasing process.

How Merchant Exporters Can Make Money Through Consolidation

The exporter may earn an agreed trading margin or sourcing service fee, depending on the commercial model.

For example, suppose a buyer purchases several product categories through one merchant exporter.

The exporter negotiates procurement prices and includes the agreed commercial margin in the selling quotation.

Alternatively, a sourcing agreement may provide for a defined service fee.

However, these are different business structures.

The tax, invoicing and contractual arrangements should reflect the actual transaction.

The exporter should understand whether it is purchasing and reselling the products or acting as a sourcing service provider.

The appropriate legal and commercial arrangements may differ.

The business must also account for product inspection, storage, documentation, shipping coordination and other expenses.

Why Manufacturers May Not Offer the Same Flexibility

A manufacturer may specialize in a limited product range.

It may not have the capability or authorization to manufacture unrelated products.

For example, a company producing a particular type of tablet may not produce sterile surgical devices.

Another manufacturer may specialize in approved herbal formulations.

Therefore, a buyer requiring multiple categories may need several suppliers.

A merchant exporter can help coordinate those suppliers.

This is a genuine advantage of the trading model.

However, the exporter should never claim that one manufacturer produces every item if that is not true.

Manufacturer identity and traceability must remain accurate.

The Limitations of Multi-Product Consolidation

Consolidation can become difficult when the product list is too broad.

For example, an exporter may be coordinating ten different manufacturers.

Each has its own production schedule.

Some products may require different destination-country registrations.

The buyer may need separate technical dossiers.

Different products may also have different shelf lives.

The exporter must manage this complexity carefully.

For startups, beginning with a limited number of related products may be more practical than attempting to consolidate an entire hospital procurement catalogue.

A focused portfolio can improve the business's ability to control quality and delivery.

Strategy 3: Simple-Formula Contract Manufacturing Model

The third strategy is contract manufacturing.

This model is particularly relevant to entrepreneurs who want to develop a product under their own brand without owning a manufacturing factory.

A contract manufacturing arrangement involves one company engaging an appropriately qualified manufacturer to produce products according to an agreed contract.

The manufacturer performs the authorized production activities.

The company commissioning the product may participate in brand development, product specifications, commercial planning or other agreed responsibilities.

For example, an Indian entrepreneur may want to introduce an approved formulation under a suitable brand arrangement.

Instead of constructing a factory, the entrepreneur works with a manufacturer that already has the required facilities and authorizations.

However, the arrangement must satisfy the applicable licensing and product-specific requirements.

What Does Simple-Formula Contract Manufacturing Mean?

The video describes this model using products with relatively few ingredients.

For example, a business might consider a formulation with a limited number of components and request a manufacturer to produce it under an agreed brand.

However, ingredient count is not a reliable measure of regulatory or manufacturing simplicity.

A medicine containing one active pharmaceutical ingredient can still require extensive stability testing, manufacturing validation and regulatory documentation.

A product containing several ingredients may already have an established and validated manufacturing process.

Therefore, entrepreneurs should not select pharmaceutical formulations simply because the ingredient list is short.

The more useful questions are:

Is the formulation already approved or otherwise legally eligible for the proposed market?

Does the manufacturer have the necessary authorization?

Is the manufacturing process established?

Are appropriate technical and quality documents available?

Can the product be supplied in the required quantity?

These factors determine practical feasibility.

A Practical Contract Manufacturing Example

Imagine that an entrepreneur wants to develop a pharmaceutical brand.

The entrepreneur identifies an existing formulation that may be suitable for a particular market.

The entrepreneur then contacts a licensed Indian manufacturer.

The manufacturer provides information about its available product, manufacturing arrangements and relevant documentation.

The parties discuss whether the product may be supplied under a suitable third-party manufacturing or brand arrangement.

The entrepreneur may be responsible for agreed branding and commercial activities.

The manufacturer remains responsible for its licensed manufacturing operations.

Other legal responsibilities depend on the exact structure.

Before commercial production, the parties must confirm the appropriate licensing arrangement, approved product particulars, labelling and destination-market requirements.

This is more complex than merely printing a new brand name on medicine packaging.

Understanding Contract Manufacturing and Loan Licensing in India

India's Drugs Rules, 1945 provide loan-licensing arrangements for specified drug-manufacturing activities.

For example, Form 24A is associated with an application for a loan licence for eligible drug categories, while Form 25A is a corresponding licence.

Other product categories may involve different forms, including Form 27A and Form 28A.

The applicable requirements depend on the drug and proposed business arrangement.

A loan licence is not automatically required for every ordinary merchant-export transaction.

Likewise, a third-party manufacturing agreement does not automatically exempt the business from a licence where one is legally required.

The entrepreneur must clarify whether the company is merely purchasing finished products for export, commissioning manufacture under a legally permitted arrangement or acting in another regulated capacity.

This should be reviewed with the relevant State Licensing Authority and appropriately qualified regulatory professionals.

Why Contract Manufacturing Can Be Attractive to Startups

One potential advantage is that the entrepreneur does not need to finance an entire manufacturing facility.

The manufacturer may already have suitable equipment, technical personnel and quality systems.

This can allow the startup to concentrate on commercial activities such as market research, brand development and buyer relationships.

Another potential advantage is access to existing manufacturing expertise.

The manufacturer may be familiar with the relevant formulation and its production requirements.

However, contract manufacturing is not automatically a low-investment model.

The manufacturer may require substantial minimum order quantities.

There may be charges for packaging development, regulatory documentation, stability testing or other activities.

The startup must evaluate all these costs.

Who Owns the Product Formula?

This is an important commercial question.

Suppose an entrepreneur asks a manufacturer to produce a product under a new brand.

Does the entrepreneur automatically own the formulation?

Not necessarily.

The manufacturer may be supplying its existing proprietary formulation.

The startup may own only the brand name and certain agreed commercial rights.

Alternatively, a company may commission development of a new formulation and negotiate specific intellectual-property rights.

These arrangements must be defined in the contract.

A startup should not assume that paying for manufacturing automatically creates ownership of the formula or technical dossier.

The agreement should clarify formulation rights, use of technical information, confidentiality and what happens if the business changes manufacturers.

The Importance of Product Registration

Suppose the entrepreneur wants to export a contracted pharmaceutical product to another country.

An Indian manufacturing licence does not automatically permit commercial sale in that destination.

The importing country may require product registration, an authorized local importer or other permissions.

The approved manufacturer and product particulars may also be linked to the registration.

Changing the manufacturer, formula or manufacturing site may trigger additional regulatory requirements.

Therefore, startups should identify the target country before investing heavily in product branding or manufacturing.

A product that can be sold in one market may require substantial additional documentation before entering another.

Strategy 4: Multi-Ingredient Toll Manufacturing Model

The fourth strategy is toll manufacturing.

This is a more specialized form of outsourced manufacturing arrangement.

In a typical toll manufacturing business model, one company owns or supplies specified raw materials or other inputs.

Another company processes those materials according to an agreed arrangement and charges for the manufacturing service.

The commercial structure differs from a simple arrangement in which a manufacturer purchases all ingredients and sells a completed product.

However, the exact meaning of toll manufacturing varies between industries and contracts.

In pharmaceuticals, the arrangement must comply with all applicable manufacturing and quality requirements.

Owning the ingredients does not authorize an unlicensed trader to manufacture medicines.

How Does Toll Manufacturing Work?

Imagine that a company has a product concept requiring several different ingredients.

The company identifies suitable suppliers for those materials.

The company also identifies a licensed manufacturing facility capable of producing the proposed product.

Under an appropriate agreement, the parties establish responsibilities for sourcing, receiving, testing and processing the materials.

The manufacturer performs the authorized manufacturing operations.

The finished product is evaluated and released according to the applicable quality requirements.

The company commissioning the product pays the agreed manufacturing charges and other relevant expenses.

However, pharmaceutical toll manufacturing is not simply informal job work.

The manufacturer must have the required authorization and appropriate quality systems.

Raw-material suppliers must be suitably qualified.

The formula and manufacturing process must meet the applicable legal and technical requirements.

What Is the Difference Between Contract Manufacturing and Toll Manufacturing?

In a conventional finished-product contract manufacturing arrangement, the manufacturer may purchase the ingredients and packaging materials.

It then manufactures and supplies the finished product at an agreed price.

In a toll manufacturing arrangement, the company commissioning production may supply or retain ownership of specified materials.

The manufacturing facility charges for processing or other agreed activities.

For example, in one commercial arrangement, a manufacturer quotes a finished-product price that includes raw materials, manufacturing and packaging.

In another arrangement, the customer may bear the cost of approved ingredients separately and pay the manufacturer for the processing work.

These are broad commercial distinctions.

They do not replace the legal definitions and responsibilities applicable to a specific regulated pharmaceutical transaction.

The parties must establish the actual structure through appropriate contracts.

Why Some Entrepreneurs Consider Toll Manufacturing

One potential reason is greater control over ingredient sourcing.

For example, a company may want to use a particular approved raw-material supplier.

Another reason may be to coordinate several different materials through a defined manufacturing arrangement.

The company may also want clearer visibility into raw-material and processing costs.

In certain circumstances, these arrangements may offer commercial advantages.

However, they can also create additional complexity.

The company commissioning production may need more working capital to purchase materials before manufacturing begins.

It may also need to manage supplier qualification, inventory, material losses and other issues.

Therefore, toll manufacturing is not automatically cheaper than ordinary contract manufacturing.

Why Toll Manufacturing Is More Complicated Than It Appears

Imagine that a startup wants to manufacture a multi-ingredient pharmaceutical product.

The entrepreneur identifies five ingredient suppliers.

Each offers an attractive quotation.

The entrepreneur decides to purchase the ingredients separately and deliver them to a licensed manufacturing unit.

At first glance, this appears to be an easy way to reduce manufacturing costs.

However, several important questions arise.

Are all the materials of the required pharmaceutical quality?

Have the suppliers been qualified?

Will the manufacturer accept raw materials procured by an outside company?

Who is responsible for sampling and testing?

Who investigates a failed raw-material test?

Who pays for rejected ingredients?

Who controls storage conditions?

Who ensures that the formulation is authorized?

Who maintains batch manufacturing records?

Who releases the finished product?

Who is responsible if a quality defect is discovered after export?

These questions demonstrate why pharmaceutical toll manufacturing requires careful planning.

The business is not simply about purchasing ingredients from the cheapest suppliers.

Raw Material Sourcing and Supplier Qualification

In regulated pharmaceutical manufacturing, raw materials must meet defined specifications.

For example, an active pharmaceutical ingredient must satisfy applicable quality requirements.

Excipients and packaging materials must also be suitable for the intended product.

The manufacturing company needs appropriate controls for incoming materials.

This may include supplier qualification, documentation review, testing and traceability.

An entrepreneur cannot assume that a material is suitable merely because it has the same ingredient name as another material.

Different grades may have different intended applications.

For example, an industrial-grade ingredient should not be substituted for an appropriate pharmaceutical-grade material.

The specific requirements depend on the formulation and regulatory framework.

Why a Written Quality Agreement Is Essential

When pharmaceutical manufacturing activities are outsourced, responsibilities must be clearly defined.

The World Health Organization's Good Manufacturing Practice framework addresses contract manufacturing and testing.

Similar principles appear in guidance issued by other major regulatory authorities.

For example, suitable agreements should define who is responsible for raw-material specifications, manufacturing, testing and product release.

They should also address quality problems and changes to the process.

A commercial purchase order alone is not always sufficient to define these responsibilities.

The parties may require a separate technical or quality agreement.

The agreement should be prepared with appropriate pharmaceutical quality and regulatory expertise.

This is especially important where several suppliers and manufacturing activities are involved.

Can a Startup Develop Its Own Pharmaceutical Formula?

An entrepreneur may have an idea for a new medicine or combination product.

However, pharmaceutical formulation development is a specialized activity.

A startup should not assume that combining several ingredients will automatically produce a safe and effective medicine.

A formulation must be evaluated for its intended use.

Important considerations may include ingredient compatibility, stability, dose, manufacturing controls and regulatory status.

Some new formulations or fixed-dose combinations may require additional permissions or scientific evidence.

In India, certain new or otherwise unapproved drugs intended solely for export may involve specific CDSCO procedures.

The exporting country and the destination country may both impose requirements.

Therefore, formulation development should be undertaken through appropriately qualified professionals and authorized facilities.

A simple-looking medicine can still involve substantial regulatory complexity.

Is Toll Manufacturing Always Cheaper?

No.

The video presents toll manufacturing as a potentially cheaper and more efficient option.

It can be commercially attractive in some circumstances.

However, cost reduction is not guaranteed.

Suppose a manufacturer already purchases ingredients in large quantities.

Because of its established supplier relationships, it may obtain better prices than a startup purchasing smaller quantities.

The manufacturer may also have optimized production and testing arrangements.

A startup sourcing ingredients independently may pay more for transport, testing, inventory and coordination.

These additional expenses can eliminate any apparent savings.

Therefore, toll manufacturing should be evaluated using a complete cost comparison.

The correct question is not:

"Can I purchase ingredients cheaply?"

The better question is:

"Can this entire approved sourcing and manufacturing arrangement produce a compliant finished product at a commercially attractive total cost?"

A Simple Financial Comparison

Let us take a hypothetical example.

A licensed manufacturer offers a finished pharmaceutical product under a suitable contract arrangement for ?100 per unit.

The price includes the agreed materials, manufacturing, testing and packaging.

A startup believes that sourcing ingredients separately will reduce the cost.

It estimates:

Raw materials: ?58 per unit.

Manufacturing service: ?20 per unit.

Packaging: ?10 per unit.

The apparent total is ?88 per unit.

At first glance, the startup expects to save ?12 per unit.

However, this estimate may exclude several expenses.

Additional supplier qualification, incoming material testing, transport, rejected materials, inventory financing and other costs may increase the total.

Suppose these additional expenses equal ?15 per unit.

The full estimated cost becomes ?103.

In this hypothetical example, toll manufacturing is more expensive than the manufacturer's original ?100 quotation.

This does not prove that toll manufacturing is always unattractive.

It demonstrates why entrepreneurs must calculate complete costs instead of comparing only ingredient and processing prices.

All figures are illustrative and are not current market quotations.

Which of the Four Models Is Best for a Startup?

The four models solve different business problems.

Small-batch specialization focuses on defined products and manageable order requirements.

Multi-product consolidation focuses on coordinating a variety of products from qualified suppliers.

Contract manufacturing focuses on producing products through an authorized manufacturing partner under an appropriate agreement.

Toll manufacturing focuses on a more complex outsourcing structure in which the commissioning business may control or supply specified materials.

For a beginner with limited capital, multi-product sourcing or a clearly defined small-batch opportunity may sometimes be more manageable than developing a new formulation.

For a startup interested in its own brand, an established licensed contract manufacturer may offer a suitable route.

For a business with greater technical knowledge, adequate working capital and appropriate professional support, toll manufacturing may deserve investigation.

However, none of these models is automatically the best.

The correct choice depends on the product, buyer, manufacturing arrangement and applicable laws.

The Important Difference Between a Merchant Exporter and a Manufacturer

A merchant exporter generally sources products from manufacturers and supplies them to buyers.

It does not necessarily own or operate the manufacturing facility.

A manufacturer performs the regulated production activities under its applicable authorization.

A marketing company may be involved in developing and promoting a brand.

Depending on the business arrangement, these roles can overlap.

However, the legal responsibilities should not be confused.

A merchant exporter should not claim to hold a manufacturing licence merely because the supplier is licensed.

Similarly, a company that commissions production under a regulated arrangement may need specific authorizations of its own.

The exact requirements depend on the product category and activities.

Before starting, entrepreneurs should determine which role their company will actually perform.

Why Medicine Labels Show Manufactured By and Marketed By

Many pharmaceutical products display information identifying the manufacturer and the marketing company.

This reflects the fact that manufacturing and commercial marketing may be performed by different organizations.

For example, a product may be manufactured by a licensed pharmaceutical company and marketed under an authorized commercial arrangement involving another business.

However, the appearance of these two names does not mean that anyone can freely launch medicines under a brand without regulatory obligations.

Medicine labelling must comply with the applicable rules.

The manufacturing company and other relevant parties may have specific responsibilities.

For an Indian startup, understanding these distinctions is essential before developing a private-label pharmaceutical brand.

A trader, marketer, loan-license holder and manufacturing-license holder are not automatically the same legal entity or role.

The exact business arrangement must be properly established.

Why Pharmaceutical Compliance Must Come Before Marketing

Healthcare products affect patient safety.

Therefore, the business model cannot be selected only according to commercial convenience.

For example, a startup may want to manufacture a product through a small factory because the manufacturer offers flexible quantities.

However, if the factory does not have the necessary authorization for that product, the arrangement may not be suitable.

Similarly, an international buyer may want a generic medicine that is not approved in the destination country.

The exporter cannot assume that a small trial shipment bypasses the market-entry requirements.

A pharmaceutical export project should begin by confirming the legal status of the proposed product and manufacturer.

India's Drugs and Cosmetics Act, Drugs Rules and applicable regulatory notifications establish important requirements.

The revised Schedule M framework also strengthens expectations concerning pharmaceutical Good Manufacturing Practices.

Startups should verify the manufacturer's compliance with the requirements currently applicable to its operations.

The importing country's rules must be examined separately.

Pharmaceutical, Ayurvedic, Cosmetic and Nutraceutical Products Are Not the Same

Another important point for beginners is that different healthcare-related products fall under different regulatory frameworks.

For example, a conventional pharmaceutical medicine may require authorization under the applicable drug regulations.

An Ayurvedic medicine has its own legal and licensing requirements.

A cosmetic product is regulated under the relevant cosmetics framework.

A nutraceutical or food supplement may be regulated as a food product, depending on its composition and intended use.

These categories should not be confused.

For instance, the Indian regulatory system includes loan-licensing arrangements for eligible Ayurvedic, Siddha and Unani medicines.

But the applicable forms and licensing procedures are different from those used for conventional pharmaceutical products.

Likewise, a food supplement should not automatically be marketed as a medicine.

A merchant exporter should establish the correct product category before choosing a manufacturing partner.

What Documents Should a Startup Verify?

The required documentation depends on the product and destination country.

However, a pharmaceutical merchant exporter may need to examine several important records.

These may include:

Importer Exporter Code, unless exempted.
Relevant business and tax documentation.
Appropriate drug wholesale or other business licences where applicable.
Manufacturer's licence covering the relevant product.
Applicable loan licence or other authorization where required.
Product specifications.
Batch-specific Certificate of Analysis.
GMP-related documentation.
Stability and shelf-life information.
Product registration or market-authorization documents where applicable.
Commercial invoice.
Packing list.
Shipping bill or other applicable export customs declaration.
Air waybill or bill of lading.
Certificate of origin where required.
Relevant destination-country import approvals.
Appropriate quality and commercial agreements.

Additional documents may be necessary for specific products or markets.

Not every document applies to every transaction.

The important point is that the exporter must identify the correct requirements before accepting a commercial order.

How Can Small Exporters Protect Their Working Capital?

The video begins with an important commercial challenge: buyers sometimes ask new suppliers to provide goods on credit.

A startup should not assume that offering credit is the only way to enter a market.

The buyer's payment terms are a matter of commercial negotiation.

A startup may explore advance payment, suitable letters of credit or other risk-managed arrangements.

However, not every international buyer will accept advance payment.

A buyer may also request samples, product registration or an initial supplier evaluation.

The entrepreneur should assess the buyer's credibility and the financial exposure involved.

For example, if a startup has limited capital, it should avoid committing its entire investment to an order with uncertain payment arrangements.

A confirmed purchase order also does not automatically guarantee payment.

The contract, payment instrument, buyer credibility and shipment conditions matter.

The objective should be to develop commercially practical arrangements that protect the business.

Can Product Specialization Reduce the Need to Offer Credit?

A specialized product or service may give the exporter a stronger reason to negotiate suitable terms.

For example, a buyer with a very specific requirement may value a supplier who can reliably coordinate the product.

However, this does not guarantee that the buyer will agree to advance payment.

Credit decisions depend on buyer policies, competition and the transaction.

Therefore, a strong value proposition can support negotiations, but cannot eliminate financial risk.

For startups, the best approach is to combine specialization with careful buyer verification and risk-managed payment arrangements.

How to Find Buyers for Each Market-Entry Model

Different strategies may require different customer searches.

For small-batch specialization, the exporter can investigate distributors with clearly defined product requirements and manageable order volumes.

For multi-product consolidation, potential buyers may include healthcare importers and distributors seeking several related product categories.

For contract manufacturing, the exporter may approach suitable private-label businesses, authorized marketers or distributors requiring a particular approved product.

For toll manufacturing, potential opportunities may involve established companies with defined manufacturing and sourcing requirements.

However, the exporter should avoid contacting buyers with only a general catalogue.

The company should explain the specific service or sourcing advantage it can provide.

A good business presentation should answer:

What products can be supplied?

Which qualified manufacturers are involved?

What technical documents are available?

Which quantities are commercially feasible?

What market authorizations apply?

How will orders be coordinated?

What commercial terms can be offered?

The objective is to provide reliable information and establish a practical business discussion.

A Practical Introductory Email for International Pharma Buyers

Subject: Pharmaceutical Sourcing from India – Flexible Product and Supply Arrangements

Dear Procurement Team,

Greetings from Barai Overseas, India.

We are exploring opportunities to support international pharmaceutical and healthcare distributors through suitable sourcing arrangements with qualified Indian manufacturers.

Our focus includes understanding buyer requirements relating to product selection, order quantities, packaging, technical documentation and dependable supply.

Depending on the product and regulatory requirements, we can explore sourcing arrangements involving selected small-batch quantities, multiple product categories or suitable contract manufacturing partnerships.

We would be interested in understanding whether your organization currently requires additional Indian suppliers or support with specific product sourcing challenges.

Based on your requirements, we can coordinate available manufacturer details, product specifications, relevant documentation and commercial quotations for your evaluation.

We understand the importance of product registration, quality assurance and applicable import requirements in pharmaceutical trade.

We would welcome the opportunity to discuss whether a suitable supply arrangement can be developed.

Best regards,

Barai Overseas

https://www.exportimport.guru/

This communication focuses on the company's sourcing role and does not claim ownership of a manufacturing facility or product authorization.

Product-specific information should be added only after verifying the relevant details.

How to Select the Right Model Based on Your Budget

A startup should not choose a business model simply because another entrepreneur has been successful using it.

The selection should be based on its own capabilities.

Consider the following questions.

How much working capital is available?

Does the company already have qualified manufacturing contacts?

Does the entrepreneur understand the product category?

Is there a genuine international buyer requirement?

Does the proposed product require destination-country registration?

Can the manufacturer supply the required quantities?

Will the startup need to purchase raw materials?

Who will pay for manufacturing and testing?

How will quality complaints be managed?

What payment terms are commercially feasible?

Which party will hold the necessary product authorization?

The answers can help narrow the available options.

For example, a startup with limited capital and no formulation expertise may be better positioned to begin by coordinating suitable existing products.

A company seeking to develop its own brand may need a more structured manufacturing and regulatory plan.

A company considering toll manufacturing should be prepared for additional technical responsibilities and potentially greater working-capital requirements.

A Practical Market-Entry Decision Framework

If your main challenge is finding a supplier willing to support a manageable product quantity, investigate small-batch specialization.

If your customer needs several different products from multiple manufacturers, investigate multi-product consolidation.

If you want a product under an agreed brand without owning a factory, investigate licensed contract manufacturing.

If you have a justified need to control ingredient procurement and a qualified manufacturer can support the arrangement, investigate toll manufacturing.

However, treat these as starting points for evaluation.

They are not guarantees of profitability or regulatory suitability.

The product and destination market should always be examined first.

The Biggest Financial Risk in Toll Manufacturing

One particularly important issue is ownership of raw materials.

In a toll manufacturing arrangement, the company commissioning the work may purchase substantial quantities of ingredients.

If the manufacturing project is delayed or cancelled, those ingredients may remain unused.

Some materials may have limited shelf lives.

Others may require controlled storage.

If the raw materials fail testing, the startup may face additional losses.

The business must also consider whether ingredients can be used in another product.

Therefore, the entrepreneur should avoid purchasing materials before the manufacturing partner has reviewed and approved the relevant specifications and sourcing arrangements.

A written agreement should establish responsibility for rejected stock, material losses, storage, expiry and project termination.

This is an important part of protecting a small business.

The Importance of Manufacturer and Supplier Agreements

A startup should avoid operating complex pharmaceutical projects entirely through informal WhatsApp messages.

Written agreements provide clarity.

For example, a contract manufacturing agreement may address pricing, order quantities, delivery schedules, confidentiality and brand rights.

A technical quality agreement may address manufacturing specifications, testing, change control and product release.

A sourcing agreement may define the merchant exporter's role and compensation.

A distribution agreement may establish the overseas buyer's responsibilities and territory.

These are different types of agreements.

They should be prepared according to the actual business arrangement.

Qualified legal and regulatory professionals can help ensure that the agreements reflect the applicable laws and responsibilities.

A simple purchase order may be sufficient for some routine transactions.

But more complex manufacturing and distribution relationships generally require greater contractual clarity.

A 30-Day Preparation Plan for Small-Budget Pharma Startups

Days 1–5: Understand the Four Models

Study small-batch specialization, multi-product consolidation, contract manufacturing and toll manufacturing.

Identify the responsibilities and investment requirements of each approach.

Days 6–10: Select a Product Category

Choose a defined product category.

Study its intended use, manufacturing requirements and basic regulatory status.

Avoid starting with too many unrelated products.

Days 11–15: Evaluate Qualified Manufacturers

Identify suitable Indian manufacturers.

Request information concerning product availability, manufacturing authorization, minimum order quantities and quality documentation.

Days 16–20: Study International Buyer Requirements

Identify potential importers or distributors.

Understand the products and quantities they require.

Determine whether the proposed market-entry model would solve a genuine problem.

Days 21–25: Prepare Commercial Costing

Estimate procurement, manufacturing, testing, packaging, logistics and other relevant expenses.

Compare different sourcing models where appropriate.

Days 26–30: Develop the Business Proposal

Prepare a product-focused presentation.

Clarify the company's actual role.

Begin suitable buyer discussions.

Review the feedback before making substantial investments.

This is a business-preparation roadmap.

It does not guarantee that a pharmaceutical product can be registered, manufactured and exported within 30 days.

The actual timeline depends on regulatory requirements, manufacturer readiness and commercial arrangements.

Common Mistakes Startup Merchant Exporters Should Avoid

One common mistake is assuming that every market can be entered only by offering goods on credit.

Another is choosing a product without understanding why the buyer would purchase it from a new supplier.

Some entrepreneurs believe that smaller factories always produce better-quality medicines.

Others assume that a small order quantity automatically means low manufacturing costs.

Another mistake is attempting multi-product consolidation without checking storage, registration and shipment compatibility.

Some startups select contract manufacturing merely because a formula contains few ingredients.

Others believe that toll manufacturing must be cheaper because they can source ingredients separately.

Another serious mistake is commissioning a new drug formulation without understanding licensing and regulatory requirements.

Some entrepreneurs also confuse merchant exporting, marketing arrangements and loan licensing.

Others overlook product registration in the destination country.

Finally, many startups calculate profit using only the manufacturer's quotation while ignoring testing, packaging, financing and logistics.

These mistakes can create financial losses and compliance problems.

The correct approach is to evaluate the entire business model before committing capital.

Why the Merchant Exporter's Role Can Be Valuable

An international pharmaceutical buyer may need more than a product catalogue.

The buyer may need a suitable manufacturer, reliable documentation, multiple product categories or help coordinating a complex supply arrangement.

A merchant exporter who understands these requirements can provide meaningful services.

For example, a qualified sourcing partner may help identify manufacturers capable of meeting a specific product requirement.

It may coordinate relevant quotations and available documents.

It may help manage communication between the manufacturer and overseas importer.

It may also support shipment planning through suitable logistics partners.

However, the exporter must not promise services or regulatory capabilities it does not actually possess.

The strongest merchant-export business is built around a clearly defined and professionally executed role.

This value can remain important even when the exporter does not own a factory.

The Bigger Lesson: Four Models, Four Different Ways to Solve Buyer Problems

The four market-entry strategies discussed in this article demonstrate that pharmaceutical business is not limited to one commercial approach.

Small-batch specialization can help address certain buyer quantity requirements.

Multi-product consolidation can reduce sourcing complexity for customers requiring several products.

Contract manufacturing can help a business develop an appropriately authorized branded supply arrangement without owning production facilities.

Toll manufacturing can create a different structure for companies that need greater involvement in ingredient procurement and outsourced processing.

However, each strategy must be evaluated according to its actual technical, regulatory and commercial obligations.

A startup should not choose a more complicated model simply because it appears more profitable.

The best model is the one that matches the buyer's requirement and can be operated reliably with the company's available knowledge and capital.

Final Thoughts: How Small-Budget Indian Startups Can Enter Pharma Exports

A small investment does not automatically prevent an entrepreneur from exploring the pharmaceutical export industry.

But limited capital makes strategic decisions even more important.

A new exporter should not try to compete with large pharmaceutical companies only through lower prices, longer credit periods or unsupported quality claims.

Instead, the entrepreneur can investigate how to create useful value within the existing supply chain.

For some startups, this may mean specializing in a clearly defined product with manageable order quantities.

For others, it may mean coordinating multiple products from qualified manufacturers.

Entrepreneurs interested in their own brands may investigate legally appropriate contract manufacturing.

More experienced businesses with suitable technical and financial resources may consider toll manufacturing arrangements.

However, none of these models removes the need for genuine product quality, correct licensing and destination-country compliance.

Before investing, understand exactly what your company will do.

Will you purchase and export finished products?

Will you coordinate sourcing for an international buyer?

Will you commission manufacturing under an approved arrangement?

Or will you take responsibility for supplying raw materials to a licensed manufacturing partner?

Each choice changes the business's responsibilities and risks.

The most important principle is simple:

A successful pharmaceutical startup does not necessarily need its own factory. It needs the right business model, qualified manufacturing partners, a clear customer requirement and the ability to execute the transaction responsibly.

At Barai Overseas, we focus on helping Indian entrepreneurs understand pharmaceutical product selection, manufacturer sourcing, international market research, business-model development and practical export execution.

Our objective is to help startup merchant exporters build knowledge-based businesses and make informed decisions before committing their limited investment.

Watch Our Original Video

4 Market Entry Strategies for Small Budget Pharma Startups

https://www.youtube.com/watch?v=Pl88QcVAVLs

For more practical export-import business learning resources, visit:

https://www.exportimport.guru/

Useful Official and Technical References